BR6-21373-80288
4 vaccinations
4 coded responses
15 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 045 / ME
- Registered
- 2021-10-01
- Relationship
- Adult relative or friend
- Guardian
- 3PV-34164-30127
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-06
Dose 1 — Pfizer-BioNTech
-
2021-02-27
Dose 2 — Pfizer-BioNTech
-
2021-10-01
Registered in v-safe
-
2021-10-14
Dose 3 — Pfizer-BioNTech
-
2022-04-14
Survey response — 6 months, dose 3, dependentMedDRA: COVID-19, Chemotherapy, Pre-existing disease, Surgery — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chemotherapy for breast cancer. Covid infection(mild and responded well to the antiviral meds) Recovering from surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Report sent to call center — 6 months, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-20
Call successfulDoes not wish to fill out VAERS report
-
2022-05-02
Dose 4 — Pfizer-BioNTech
- 2022-05-02
-
2022-05-04
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2022-05-05
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2022-05-07
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-08
Survey response — days 1–6 daily, dose 4, dependentMedDRA: Adverse reaction, Breast cancer — Feeling: Poor · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Symptoms could be be due to breast cancer treatmentsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-09
Survey response — day 7, dose 4, dependentMedDRA: Breast cancer — Feeling: Fair · Fatigue or tiredness, NauseaFree text: Symptoms may be due to breast cancer treatmentMedDRA releases: 2024-11 · check-in free text available
- 2022-05-16
- 2022-05-23
-
2022-05-30
Survey response — day 28, dose 4, dependentMedDRA: Pre-existing disease — Feeling: FairFree text: Effects of radiation treatment for breast cancer. NOT related to CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-06-06
- 2022-06-13
- 2022-08-01
- 2022-10-31
- 2023-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-06 | Pfizer-BioNTech | No |
| 2 | 2021-02-27 | Pfizer-BioNTech | No |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-05-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 3, dependent
Symptoms: Chemotherapy for breast cancer. Covid infection(mild and responded well to the antiviral meds) Recovering from surgery
Release 11 — days 1–6 daily, dose 4, dependent
Systemic reaction (other): Symptoms could be be due to breast cancer treatments
Release 11 — day 7, dose 4, dependent
Systemic reaction (other): Symptoms may be due to breast cancer treatment
Release 11 — day 28, dose 4, dependent
Symptoms: Effects of radiation treatment for breast cancer. NOT related to Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chemotherapy | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Surgery | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Breast cancer | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release